前沿快讯
聚焦肿瘤与肿瘤类器官最新研究,动态一手掌握。

美国最大国家肿瘤登记处中的新发乳腺癌病例比较研究

Comparison of incident breast cancer cases in the largest national US tumor registries

DOI 原文链接
用sci-hub下载
ℹ️
如无法下载,请从 Sci-Hub 选择可用站点尝试。
影响因子:5.1
分区:医学1区 Top / 肿瘤学2区
发表日期:2025 Jan 01
作者: Jennifer K Plichta, Samantha M Thomas, Tori C Chanenchuk, Kelley Chan, Terry Hyslop, E Shelley Hwang, Rachel A Greenup
DOI: 10.1002/cncr.35525

摘要

本研究比较了国家癌症数据库(NCDB)和监测、流行病学及终末结果计划(SEER)中的新发乳腺癌(BC)病例,与全国癌症统计(USCS)进行对比。分析对象为2010-2019年在NCDB和SEER中诊断的恶性或原位乳腺癌患者。通过将NCDB和SEER中的病例数占USCS病例总数的比例,估算病例覆盖率。结果显示,USCS报告了3,047,509例患者;其中77.5%的患者被NCDB纳入,46.0%的患者被SEER纳入。不同性别患者的病例识别存在显著差异(p < 0.001)。男性患者中,84.1%被NCDB覆盖,而女性患者中此比例为77.5%。SEER中,女性的病例覆盖率优于男性(46.1%对比43.5%)。不同种族/族裔的病例覆盖率也存在显著差异(p < 0.001)。在NCDB中,非西班牙裔白人(78.2%)、非西班牙裔黑人(77.7%)和非西班牙裔亚裔或太平洋岛民(72.5%)乳腺癌患者的病例覆盖率最高,西班牙裔则最低(56.4%),非西班牙裔美洲原住民/阿拉斯加原住民最低(41.1%)。在SEER中,亚裔或太平洋岛民(78.1%)和西班牙裔的病例覆盖率最高(69.6%),而其他亚组(非西班牙裔黑人44.8%、非西班牙裔白人42.4%、非西班牙裔美洲原住民/阿拉斯加原住民36.6%)则显著偏低。国家级肿瘤登记提供了大量乳腺癌患者数据,但在年龄、性别和种族/族裔方面存在显著差异。这提示在使用这些数据进行分析和解读时应考虑这些差异性。

Abstract

This study compared incident breast cancer cases in the National Cancer Database (NCDB) and Surveillance, Epidemiology, End Results Program (SEER) to a national population cancer registry.Patients with malignant or in situ breast cancer (BC) 2010-2019 in the NCDB and SEER were compared to the US Cancer Statistics (USCS). Case coverage was estimated as the number of patients in the NCDB/SEER as a proportion of USCS cases.The USCS reported 3,047,509 patients; 77.5% patients were included in the NCDB and 46.0% in SEER. Case ascertainment varied significantly by patient sex (both registries, p < .001). For males, 84.1% were captured in the NCDB, whereas only 77.5% of females were included. Case coverage in SEER was better for females than males (46.1% vs. 43.5%). Registries varied significantly by race/ethnicity (both p < .001). Case coverage in the NCDB was highest for non-Hispanic White (78.2%), non-Hispanic Black (77.7%), and non-Hispanic Asian or Pacific Islander (72.5%) BC patients, and lowest for Hispanic (56.4%) and non-Hispanic American Indian/Alaska Native (41.1%) patients. In SEER, case coverage was highest for non-Hispanic Asian or Pacific Islander (78.1%) and Hispanic (69.6%) patients and it was significantly lower for all other subgroups (non-Hispanic Black, 44.8%; non-Hispanic White, 42.4%; and non-Hispanic American Indian/Alaska Native, 36.6%).National US tumor registries provide data for a large sampling of breast cancer patients, yet significant differences in case coverage were observed based on age, sex, and race/ethnicity. These findings suggest that analyses using these data sets and interpretation of findings should account for these meaningful variances.